Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock Now Rated “Moderate Buy” by Wall Street Analysts
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have issued a buy rating […]
8 Nov 08:45 · The Markets Daily